Please assess the completion status of the following clinical trial:

Trial Title: Multi-centre Failed Bowel Prep RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Anyone undergoing a repeat colonoscopy due to failed bowel preparation at index colonoscopy. Failure is defined as preparation quality inadequate to detect lesions \> 5 mm after washing and requiring a shortened colonoscopy interval as a result.~2. Age \> 18 years~3. Outpatient colonoscopy~4. Indication for full colonoscopy~Exclusion Criteria:~1. Subject refusal~2. Able to comprehend the trial~3. Index colonoscopy performed as an inpatient~4. Pregnancy or breastfeeding~5. Allergies to the employed bowel preparations~6. Any colonic surgery~7. History of ischemic colitis~8. Congestive heart failure~9. Chronic renal failure~10. Cirrhosis~11. Severe electrolyte imbalance~12. Non-adherence to index bowel preparation defined as failure to follow diet instructions and/or consume the entire volume of bowel preparation medication as prescribed for any reason (ex. eating a normal diet on the day of colonoscopy, PEG intolerance, etc...)~13. Use of bowel preparation in an off-label manner for the index colonoscopy.~14. Inability to follow verbal and written instructions in English or French.~15. Ileus, gastric outlet obstruction, gastrointestinal obstruction, bowel preforation~16. Toxic coitis or toxic megacolon~17. Acute surgical abdomen including appendicitis~18. Gastroenteritis and acute diverticulitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Regimen A (Type: EXPERIMENTAL): 4L PegLyte + 15 mg bisacodyl
- Regimen B (Type: EXPERIMENTAL): 6L PegLyte + 15 mg bisacodyl

Based on this trial design, predict the completion outcome and termination type (if applicable).